4.5 Article

3′-5′ Phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo

Journal

BIOCHEMICAL JOURNAL
Volume 443, Issue -, Pages 485-490

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BJ20111057

Keywords

bipolar disorder; lithium; 3 '-5 ' phosphoadenosine phosphate (pAp); poly(ADP-ribose) polymerase 1 (PARP-1)

Funding

  1. Centre National de la Recherche Scientifique
  2. Institut Pasteur
  3. Universite Pierre et Marie Curie
  4. Association pour la Recherche sur la Cancer [5950, 7659]

Ask authors/readers for more resources

pAp (3'-5' phosphoadenosine phosphate) is a by-product of sulfur and lipid metabolism and has been shown to have strong inhibitory properties on RNA catabolism. In the present paper we report a new target of pAp, PARP-1 [poly(ADP-ribose) polymerase 1], a key enzyme in the detection of DNA single-strand breaks. We show that pAp can interact with PARP-1 and inhibit its poly(ADP-ribosyl)ation activity. In vitro, inhibition of PARP-1 was detectable at micromolar concentrations of pAp and altered both PARP-1 automodification and heteromodification of histones. Analysis of the kinetic parameters revealed that pAp acted as a mixed inhibitor that modulated both the K-m and the V-max of PARP-1. In addition, we showed that upon treatment with lithium, a very potent inhibitor of the enzyme responsible for pAp recycling, HeLa cells exhibited a reduced level of poly(ADP-ribosyl)ation in response to oxidative stress. From these results, we propose that pAp might be a physiological regulator of PARP-1 activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available